Does USTEKINUMAB Cause Inflammatory bowel disease? 166 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 166 reports of Inflammatory bowel disease have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
166
Reports of Inflammatory bowel disease with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
2
Deaths
76
Hospitalizations
How Dangerous Is Inflammatory bowel disease From USTEKINUMAB?
Of the 166 reports, 2 (1.2%) resulted in death, 76 (45.8%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Inflammatory bowel disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 166 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Inflammatory bowel disease?
ISOTRETINOIN (692)
ADALIMUMAB (517)
INFLIXIMAB (444)
SECUKINUMAB (440)
VEDOLIZUMAB (271)
ACCUTANE (223)
METHOTREXATE (199)
TACROLIMUS (160)
ETANERCEPT (135)
IXEKIZUMAB (132)
Which USTEKINUMAB Alternatives Have Lower Inflammatory bowel disease Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE